tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Financial Statements

Compare
28 Followers

Intensity Therapeutics, Inc. Financial Overview

Intensity Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.184; its P/E ratio is ―; Intensity Therapeutics, Inc. is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -147.00K$ -179.04K$ 0.00$ 0.00$ 0.00
Operating Income$ -8.32M$ -7.63M$ -8.01M$ -6.22M$ -5.68M
EBITDA$ -10.09M$ -7.40M$ -7.88M$ -6.03M$ -5.38M
Net Income$ -10.54M$ -7.45M$ -7.89M$ -5.96M$ -5.23M
Balance Sheet
Cash & Short-Term Investments$ 14.78M$ 1.31M$ 4.54M$ 9.32M$ 8.39M
Total Assets$ 17.30M$ 1.76M$ 5.22M$ 10.15M$ 8.93M
Total Debt$ 158.00K$ 4.49M$ 2.34M$ 497.48K$ 260.27K
Net Debt$ -8.40M$ 3.18M$ -2.20M$ -8.82M$ -3.57M
Total Liabilities$ 4.13M$ 16.85M$ 13.90M$ 11.71M$ 11.31M
Stockholders' Equity$ 13.16M$ -15.10M$ -8.68M$ -1.56M$ -2.38M
Cash Flow
Free Cash Flow$ -7.21M$ -5.48M$ -6.83M$ -5.37M$ -4.42M
Operating Cash Flow$ -7.21M$ -5.48M$ -6.83M$ -5.37M$ -4.42M
Investing Cash Flow$ -6.02M$ 0.00$ 0.00$ 4.56M$ 1.70M
Financing Cash Flow$ 20.47M$ 2.25M$ 2.05M$ 6.29M$ 3.86M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

Intensity Therapeutics, Inc. Debt to Assets

Intensity Therapeutics, Inc. Cash Flow

Intensity Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis